All Stories

  1. The clinical praxis of bacteriocins as natural anti-microbial therapeutics
  2. Correction: Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies
  3. Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies
  4. Physicochemical and Anti-fungal Studies of the Pharmaceutical Co-crystal/Salt of Fluconazole
  5. Glucose metabolic reprogramming and modulation in glycerol biosynthesis regulates drug resistance in clinical isolates of Candida
  6. In Vitro Potent Anticancer, Antifungal, and Antioxidant Efficacy of Walnut (Juglans regia L.) Genotypes
  7. Immunotherapies against human bacterial and fungal infectious diseases: A review
  8. β-Nitrostyrene derivatives as broad range potential antifungal agents targeting fungal cell wall
  9. Natural products and their semi-synthetic derivatives against antimicrobial-resistant human pathogenic bacteria and fungi
  10. Quinidine drug resistance transporter knockout Candida cells modulate glucose transporter expression and accumulate metabolites leading to enhanced azole drug resistance
  11. Role of immunogenetics polymorphisms in infectious diseases
  12. Novel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes
  13. Metabolic flexibility and extensive adaptability governing multiple drug resistance and enhanced virulence in Candida albicans
  14. Glucose - The X factor for the survival of human fungal pathogens and disease progression in the host
  15. Identification of Genomewide Alternative Splicing Events in Sequential, Isogenic Clinical Isolates of Candida albicans Reveals a Novel Mechanism of Drug Resistance and Tolerance to Cellular Stresses
  16. Quorum sensing: A less known mode of communication among fungi
  17. W1038 near D-loop of NBD2 is a focal point for inter-domain communication in multidrug transporter Cdr1 of Candida albicans
  18. Molecular Basis of Substrate Polyspecificity of the Candida albicans Mdr1p Multidrug/H+ Antiporter
  19. Resistance to antifungal therapies
  20. Tools and Techniques to Study Multidrug Transporters of Yeasts
  21. Erratum: Erratum: Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric
  22. Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric
  23. MFS transporters ofCandidaspecies and their role in clinical drug resistance
  24. Antifungals: Mechanism of Action and Drug Resistance
  25. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance
  26. Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p
  27. ABC transporter Cdr1p harbors charged residues in the intracellular loop and nucleotide-binding domain critical for protein trafficking and drug resistance
  28. Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans
  29. Mechanisms of Drug Resistance in Fungi and Their Significance in Biofilms
  30. Alanine scanning of all cysteines and construction of a functional cysteine-less Cdr1p, a multidrug ABC transporter of Candida albicans
  31. In VitroEffect of Malachite Green on Candida albicans Involves Multiple Pathways and Transcriptional RegulatorsUPC2andSTP2